Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Travel reimbursement 2019 - US

Reference number
Coordinator WarOnCancer AB
Funding from Vinnova SEK 24 000
Project duration March 2019 - May 2019
Status Completed

Purpose and goal

The purpose of participating in SALSS in Washington DC was to meet strategic partners and potential investors for our expansion in the US market. We did both.

Expected results and effects

We met with strategic partners within the life-science industry and potential investors whom all showed a big interest in what we are building and the potential with WarOnCancer. This resultet in 4 booked meetings for a deeper discussion regarding investments and marketing possibilities for WarOnCancer in the US.

Planned approach and implementation

WarOnCancer participated in SALSS through a round-table discussion with leading life-science CEO:s, lead by Greg Simon - president of the Biden Cancer Initiative. WarOnCancer did also exhibit during the start-up exhibition event. This was a very good way to create interest and meet with the all the people attending.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 2 April 2019

Reference number 2019-02172

Page statistics